These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17296492)

  • 21. Epidemiology of the metabolic syndrome in the USA.
    McCullough AJ
    J Dig Dis; 2011 Oct; 12(5):333-40. PubMed ID: 21091931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
    Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
    Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of NAFLD.
    Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB
    J Insur Med; 2004; 36(1):27-41. PubMed ID: 15104027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease.
    Adams LA; Lindor KD
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of nonalcoholic fatty liver disease: current status.
    Duvnjak M; Tomasic V; Gomercic M; Smircic Duvnjak L; Barsic N; Lerotic I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():57-66. PubMed ID: 20388946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
    Wilfred de Alwis NM; Day CP
    Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK; Winn J; Poordad F
    Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
    Nomura K; Yamanouchi T
    J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.